Gene · 2041
Papers3,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Eph Receptors in Cancer. | Biomedicines | 2023 | 36830852 | PubTator, text mining | PubMed |
| Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer. | J Transl Med | 2023 | 36829199 | PubTator, text mining | PubMed |
| [Research progress on the modulation mechanism of electroacupuncture for learning and memory impairment after ischemic stroke]. | Zhongguo Zhen Jiu | 2023 | 36808522 | PubTator, text mining | PubMed |
| Prostate cancer cell-platelet bidirectional signaling promotes calcium mobilization, invasion and apoptotic resistance via distinct receptor-ligand pairs. | Sci Rep | 2023 | 36806315 | PubTator, text mining | PubMed |
| Optimization of the Lead Compound NVP-BHG712 as a Colorectal Cancer Inhibitor. | Chemistry | 2023 | 36799129 | PubTator, text mining | PubMed |
| Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach. | Biochem Pharmacol | 2023 | 36792038 | PubTator, text mining | PubMed |
| RANK signaling in osteoclast precursors results in a more permissive epigenetic landscape and sexually divergent patterns of gene expression. | PeerJ | 2023 | 36788807 | PubTator, text mining | PubMed |
| Dietary Responses of Dementia-Related Genes Encoding Metabolic Enzymes. | Nutrients | 2023 | 36771351 | PubTator, text mining | PubMed |
| The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment. | Int J Mol Sci | 2023 | 36769332 | PubTator, text mining | PubMed |
| From the Catastrophic Objective Irreproducibility of Cancer Research and Unavoidable Failures of Molecular Targeted Therapies to the Sparkling Hope of Supramolecular Targeted Strategies. | Int J Mol Sci | 2023 | 36769134 | PubTator, text mining | PubMed |
| Treatment of Advanced Non-Small Cell Lung Cancer with RET Fusions: Reality and Hopes. | Int J Mol Sci | 2023 | 36768754 | PubTator, text mining | PubMed |
| Urinary Extracellular Vesicles in Chronic Kidney Disease: From Bench to Bedside? | Diagnostics (Basel) | 2023 | 36766548 | PubTator, text mining | PubMed |
Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells. | Transl Lung Cancer Res | 2023 | 36762066 | PubTator, text mining | PubMed |
| No genetic causal association between Alzheimer's disease and osteoporosis: A bidirectional two-sample Mendelian randomization study. | Front Aging Neurosci | 2023 | 36761181 | PubTator, text mining | PubMed |
| Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension-Mechanisms and Mitigation. | Hypertension | 2023 | 36756872 | PubTator, text mining | PubMed |
| Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis. | Sci Transl Med | 2023 | 36753562 | PubTator, text mining | PubMed |
| Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer. | J Immunother Precis Oncol | 2023 | 36751659 | PubTator, text mining | PubMed |
| The factors affecting neurogenesis after stroke and the role of acupuncture. | Front Neurol | 2023 | 36741282 | PubTator, text mining | PubMed |
| Model of neural induction in the ascidian embryo. | PLoS Comput Biol | 2023 | 36735746 | PubTator, text mining | PubMed |
| Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies. | Curr Heart Fail Rep | 2023 | 36696001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2041/papers?page=15